Ticker

CMP.AU

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Okti; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; Somté, an investigative tool; Siesta 802; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, an portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, it offers software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; CURRY, a signal processing and soutce localization multi-modal neuroimaging suite; Profusion neXus Scheduler for planning for staff and time; and HD Digital Video, a plug-in software module to add synchronized digital video capabilities to sleep and EEG systems, as well as ECG Free, Profusion Plus, Siesta extended battery pack, summit IP, TCM5 FLEX transcutaneous monitors, Grael DC, and persyst software products. Further, the company offers magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; and consumables and supplies for diagnostic and research solutions. Additionally, the company provides doppler diagnostics; Nuevo LTM EEG; Orion LifeSpan MEG; and quick-cap EEG electrode arrays. Compumedics Limited was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited is a subsidiary of D & DJ Burton Holdings Pty Ltd.